Tomi Environmental Solutions (TOMZ) announced that a cell and gene therapy manufacturer has adopted SteraMist ionized hydrogen peroxide technology for its commercial-scale facility. The client has invested in multiple SteraMist systems to facilitate surface treatment and automated room fogging. To provide a transition to commercial production, the partnership includes Tomi’s standard operating procedure development package and installation and operational qualification package.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TOMZ:
- Tomi Environmental Solutions secures purchase order of $500,000 for SteraMist
- Tomi Environmental calls on cruise lines to improve decontamination
- Tomi Environmental Solutions announces $3M integration pipeline
- TOMI Environmental Receives Second Nasdaq Deficiency Notice
- TOMI Environmental Solutions Approves Key Proposals at Shareholder Meeting